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S1 Materials and methods
Chemicals.
LiCl powders were purchased from Sigma-Aldrich. The 4 M LiCl solution was buffered with 1×TE (10 mM Tris, 1 mM EDTA, pH 8.0, Sigma-Aldrich). Monovalent streptavidin was generously provided by the Howarth Lab. 1 Recombinant DNA MTase M.TaqI was produced as previously described. Sequence-specific biotinylation of plasmid DNA.
Biotin-labelled DNA was prepared by incubating double-stranded plasmids (500 ng/µL pBR322, 50 ng/µL ΦX174 or 50 ng/µL M13mp18, New England BioLabs (NEB), Ipswich, MA, USA), biotinylated AdoMet analogue (80 µM) and M.TaqI (pBR322: 1.24 µM, ΦX174: 0.13 µM, M13mp18: 0.12 µM, 1 eq. M.TaqI with respect to 5'-TCGA-3' recognition sequences on the plasmids) in NEB buffer 4 (pBR322: 50 µL, ΦX174 or M13mp18: 100 µL, 20 mM Tris-HCl, 50 mM KOAc, 10 mM Mg(OAc) 2 , 1 mM DTT, pH 7.9) at 65 °C for 1 h (Scheme S1). Plasmids were purified using the QIAquick PCR purification kit (QIAGEN, Hilden, Germany) according to the instructions of the manufacturer. Complete labelling was verified by protection of the modified plasmids against cleavage by the cognate restriction endonuclease R.TaqI. DNA samples of each labelling reaction were supplemented with R.TaqI (10 units/µg DNA, New
England BioLabs, Ipswich, MA, USA), incubated at 65 °C for 1 h and analyzed by agarose gel (1%) electrophoresis (0.5×TBE buffer, 1 h, 90 V, 0.01% GelRed) ( Figure S1 ).
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Scheme S1. M.TaqI-catalyzed transfer of an extended side chain with a biotin residue from an Sadenosyl-L-methionine cofactor analogue to adenine within the double-stranded 5'-TCGA-3' DNA sequence. (Biotin +) in the absence of R.TaqI (R.TaqI -).
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Glass nanopore fabrication.
The glass nanopores were pulled from quartz capillaries (with outer diameter 0.5 mm and inner diameter 0.2 mm) using a pipette puller (P2000, Sutter Instrument Co., Novato, CA, USA). The inner pore diameters 14 ± 3 nm (mean ± s. d.) at the tip were estimated based on a previous characterization of our fabrication method.
3
Setup and nanopore measurements. 
3) Event peak analysis
An algorithm was written to determine the positions of peaks as shown in Figure S4 . events caused by a mixture of unlabelled and protein-labelled pBR322 DNA.
2) Selection of unfolded events
The method for the selection of unfolded events is the same as shown in Figure S3 . We had 4053 unfolded events out of the 9238 events.
3) Event peak analysis
The method for detecting the peaks is the same as shown in Figure S4 . 
2) Selection of unfolded events
The method for the selection of unfolded events is the same as shown in Figure S3 . We had 807 unfolded events out of the 2381 events.
3) Event peak analysis
The method for analyzing the peak positions is the same as shown in Figure S4 . 
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2) Selection of unfolded events
The method for the selection of unfolded events is the same as shown in Figure S3 except that the first 2% part of the event was used as the detected portion in the first step since the first site occurs closer to the end of the DNA. We had 803 unfolded events out of the 2317 events.
3) Event peak analysis
The method for analyzing the peak positions is the same as shown in Figure S4 with the peak detection width 12 points. 
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2) Selection of unfolded events
The method for the selection of unfolded events is the same as shown in Figure S3 . We had 747 unfolded events out of 1803 events in the right group (272 fC˂ECD˂414 fC) and 2835 events unfolded events out of 5883 events in the left group (120 fC˂ECD˂272 fC) in Figure S17 . 
3) Event peak analysis
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4) Estimation of the distances between adjacent sites
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